All posts by imreal

RAM Technologies, Inc. and Medicare Advantage-in-a-Box Ready for CMS Changes to Value Based Insurance Design Model


Overall, the aim of the program is a complete modernization of the Medicare Advantage program and we are pleased to be able to provide our clients with the tools needed to achieve this objective.

RAM Technologies, Inc., the perennial leader in the development of enterprise software for healthcare payers administering Medicare Advantage and Special Needs plans, is proud to announce the value based benefit capabilities available with HEALTHsuite Advantage™ and Medicare Advantage-in-a-Box. The advanced functionality provides health plans with the tools they need to participate in the Centers for Medicare and Medicaid Services’ (CMS) Value-Based Insurance Design (VBID) model.

The advanced value based benefits processing capabilities available with HEALTHsuite Advantage and Medicare Advantage-in-a-Box enable health plans to identify patients who are eligible for the program and then adjust their patient responsibility accordingly. The system provides functionality to identify specific co-payments, coinsurance and / or deductibles that can be waived for patients participating in pre-defined initiatives. VBID functionality includes the ability to reduce cost shares and add supplemental benefits for enrollees with chronic conditions.

In 2020, CMS has expanded the scope of the VBID model, allowing for more health plans to participate including special needs plans (D-SNPs and I-SNPs). Additionally, the list of conditions has increased to include Chronic and Socioeconomic factors and the benefits have also been expanded to include telehealth and Social Determinants of Health (SDOH). 2020 has also seen the elimination of cost shares for high value services as well as disease specific Care Management programs.

In addition, 2021 will see even more changes to the VBID Model, including the incorporation of Hospice / End-of-Life Care which will require the ability to accurately identify members in coaching / disease management; waive the patient responsibility for procedures related to the coaching program; provide support for multiple benefit definitions; and more.

“The goal of the VBID program is to reduce overall costs and enhance the quality of care for beneficiaries. The VBID capabilities available with HEALTHsuite Advantage and Medicare Advantage-in-a-Box meet these needs and provide our clients with the ability to apply the program specific benefits to their membership,” stated Robert A. Tulio, President of RAM Technologies. “Overall, the aim of the program is a complete modernization of the Medicare Advantage program and we are pleased to be able to provide our clients with the tools needed to achieve this objective.”

RAM’s offerings, HEALTHsuite Advantage and Medicare Advantage-in-a-Box, represent a revolution in the way health plans modernize their MA administrative infrastructure. The pre-configured solution deploys out-of-the-box, ready to administer ‘Original Medicare’, thereby slashing implementation durations, eliminating risk and greatly reducing costs. This RAM offering brings robust functions and features including all of the essential core capabilities and complete integration with CMS, and delivers them in a truly innovative fashion.

In addition to the enterprise capabilities provided by HEALTHsuite Advantage and Medicare Advantage-in-a-Box, RAM also makes available solutions from their strategic alliance partners, solutions to facilitate the management of population health, quality, cost containment, analytics and more. These combined solutions represent a one-stop-shop for all of a health plan’s MA needs and the simplest solution for organizations looking to enter the MA market.

About RAM Technologies:

RAM Technologies is the industry leader in helping organizations that are interested in starting a Medicare Advantage plan. Every day more and more people are asking, “How Do I Become a Medicare Advantage Health Plan?” We offer a step-by-step process to succeed. Whether you are a health system looking to transition to Medicare Advantage or a new entity looking for Steps to Succeed as a Medicare Advantage start-up, we can help. To learn more about launching a Medicare Advantage Plan, answering the question, “What do I need to do to start a Medicare Advantage Health Plan?” call (877) 654-8810 x 4 or visit http://www.ramtechinc.com.

Share article on social media or email:

Nomis nSight Arms Financial Institutions with Real-Time Pricing Intelligence


Accessible with zero integration costs, nSight is built on a proprietary Nomis database that combines billions of financial observations with public data and third-party subscription data.

“Nomis nSight combines cutting-edge AI and billions of financial observations, public and private data to create pricing strategy insights for business users.”

Nomis Solutions, a fintech innovator focused on ensuring on-going value creation for the world’s smartest financial institutions, announced the availability of Nomis nSight, a strategic tool for optimally pricing deposits and mortgages in real time. Nomis nSight is an analytic tool for banks, lenders and credit unions that gives their teams fast and powerful information about the markets in which they compete.

Accessible with zero integration costs, nSight is built on a proprietary Nomis database that combines billions of financial observations with public data and third-party subscription data. The final output is a data and visualizations tool that equips pricing managers with the latest pricing intelligence to support smart and profitable business decisions.

“Whether you are trying to decide how to grow your deposits portfolio, or how to beat out the competition in a specific mortgage market, making smart pricing decisions requires continual analysis of large amounts of data—something that many financial institutions simply don’t have the resources to tackle,” said Frank Rohde, president and CEO of Nomis Solutions. “nSight combines cutting-edge AI and billions of financial observations, public and private data to create pricing strategy insights for business users. Whether you’re a data scientist, a deposit product manager, or mortgage loan officer, you can now make better, data-driven pricing decisions to support your business objectives. In a volatile market, deep and real-time insight into pricing is crucial to win”

Product overview

Nomis nSight supports pricing decisions for both deposits and mortgages:

nSight for Deposits

  • Quickly evaluate micro-market price sensitivity to make decisions about how to price and where to promote.
  • Evaluate competitive intensity and supply of deposit dollars within a market to help determine which markets to pursue and which to avoid.
  • Leverage Nomis’ deep market-level knowledge and proprietary data assets to score the attractiveness of any market in the US.
  • Focus marketing dollars on the right audience to maximize campaign impact.

nSight for Mortgages

  • Acquire business intelligence on how pricing cell changes will return a higher margin and more volume.
  • Gain full visibility into the pulse of the market, with live data from BankRate, LendingTree, Zillow, and others.
  • Receive actionable intelligence on where and when to post your rates, which sites are the least competitive, and at what times of day.
  • Take advantage of unique market arbitrage opportunities unknown to competitors.

Where to learn more about Nomis nSight

About the Nomis Platform

The Nomis nSight for pricing dashboard is part of the Nomis Pricing Platform™, which includes Nomis Price Optimizer™, Nomis Price Manager™, and Nomis Deal Manager™. Nomis Price Optimizer uses big-data analytics to help banks define optimal strategies to meet specified volume and profitability targets, the Nomis Deal Manager achieves consistent, personalized pricing and offers that meet both customer needs and bank goals, while Nomis Deal Manager presents pricing and offers via the front line. The Nomis Pricing Platform supports end-to-end visibility that connects back-office pricing decisions with front-line customer engagement.

About Nomis Solutions

Nomis is a fast-growing fintech and price optimization pioneer that is enabling the world’s smartest financial institutions to drive sustained, profitable growth through end-to-end customer-centric pricing capabilities. We do so through our market-leading, cloud-native Nomis Platform™ and team of experts, bringing together cutting-edge big data, machine learning, AI and mission-critical software with deep expertise in consumer behavior, pricing and the financial services industry. The Nomis Platform manages over $2.5 trillion in transaction volume, quotes a price every 60 milliseconds, empowers 14,000+ bankers, and generates nearly $800 million in value annually. To learn more, visit nomissolutions.com.

Share article on social media or email:

Chugai Implements Genedata Profiler to Accelerate Data-driven Biomarker Discovery


News Image

We chose Genedata Profiler because it is the end-to-end enterprise software able to enhance our capacity to analyze large amounts of high-dimensional ‘omic data emerging from our rapidly growing number of translational and clinical research projects.

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Chugai Pharmaceutical Co., Ltd., a leading research-based pharmaceutical company in Japan, has chosen Genedata Profiler® as one of the cornerstones of their biomarker strategy to support the efficient identification and validation of innovative, next-generation biomarkers.

“We chose Genedata Profiler because it is the end-to-end enterprise software able to harmonize our dispersed data analysis pipelines”, said Kimio Terao, Department Manager of Clinical Pharmacology at Chugai. “We need to enhance our capacity to analyze large amounts of high-dimensional ‘omic data emerging from our rapidly growing number of translational and clinical research projects. This requires domain-specific software to automate the processing, analysis, and integration of such complex molecular data types. We needed a solution that scales with us as we grow. And Genedata, who impressed us with their tremendous scientific expertise, provided this.”

Genedata Profiler is now integrated into Chugai’s data analysis pipeline and will support the company achieve ‘early Proof of Concept’, ultimately bringing innovative drugs to patients faster. Set up as a cloud-based system that is fully scalable, Genedata Profiler helps Chugai cope with the massive increase in data volume and complexity of their clinical and translational research projects. In addition, multiple levels of fine-grained access control ensure data security throughout the entire data lifecycle. And since the advanced exploratory analytics of Genedata Profiler don’t necessarily require programming skills, Chugai’s translational researchers can easily and rapidly deliver high-quality results. This holistic, data-driven approach will empower Chugai to accelerate the discovery of innovative biomarkers and will lead to a rising number of successful R&D projects.

“We are excited to enable Chugai to increase the efficiency of their R&D processes”, said Othmar Pfannes, Ph.D., CEO of Genedata. “Genedata Profiler has been successful in Europe and the US for years. The fact that a leading global biopharma company from Japan is now implementing Genedata Profiler is an important milestone in our global expansion strategy and further confirms the quality of our product. A part of our Biopharma Platform, Genedata Profiler supports our customers bring pioneering therapeutics to patients faster, so that they can live better and longer lives. We are committed to continuing to invest in the development of the Genedata Biopharma Platform to provide our customers with an enterprise workflow platform that will help them digitalize R&D to increase their speed to market.”

About Chugai Pharmaceutical

Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs.

About Genedata

Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI in their R&D, spanning early discovery all the way to the clinic. Founded in 1997, Genedata is headquartered in Switzerland with additional offices in Germany, Japan, Singapore, the UK, and the US.

http://www.genedata.com

LinkedIn | Twitter | YouTube

________________________________________

Contact

Miles Fisher-Pollard

Genedata

Public Relations

Phone: +41 61 511 85 61

pr@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Share article on social media or email:



President of TransUnion Healthcare is Newest Member of PharmaPoint Board


News Image

To have the opportunity to collaborate with a visionary team that pushes the limit on what can be done to improve a patient’s overall healthcare experience is exciting!

PharmaPoint is proud to announce that Dave Wojczynski, president of TransUnion Healthcare, has been added as the newest member of its board. Wojczynski brings more than two decades of industry experience to the leadership team.

“As we continue to grow and diversify, the input of experienced leaders is priceless,” says Mike Plaia, PharmaPoint Chairman and CEO. “I have known and worked with Dave for years. His ability to speak candidly and make decisions in a timely manner are just two of his attributes I most admire. Those, coupled with his unwavering commitment to excellence, make him a perfect addition to our leadership team.”

Before serving in his current role, Wojczynski served as senior vice president and Chief Operating Officer (COO) of TransUnion Healthcare, in which he was responsible for leading the operations and service delivery teams. Prior to joining TransUnion, Wojczynski served as COO for DAXKO, a member-based health and wellness industry software and payments provider.

“I am honored to serve as a board member for PharmaPoint,” says Wojczynski. “This company is doing significant things to disrupt the ever-changing landscape of healthcare. To have the opportunity to collaborate with a visionary team that pushes the limit on what can be done to improve a patient’s overall healthcare experience is exciting!”

Wojczynski has also held senior positions at Emageon, a diagnostic imaging software business, SourceMed, the leading provider of ambulatory surgery center software solutions, and General Electric. He received his Bachelor of Science degree at the United States Military Academy at West Point and his Master of Business Administration degree from Northwestern University’s Kellogg School of Management. Wojczynski also serves on the board for VisitPay, an online patient financial engagement platform company.

About PharmaPoint

PharmaPoint is an innovative, technology-enabled pharmacy management and software company. Through the management of outpatient retail pharmacies for hospitals, health systems and physician groups, our commitment to completing the care continuum results in improved patient health and satisfaction, reduced healthcare costs, and provides clients with a source of ancillary income. Additionally, XchangePoint, our proprietary integrated workflow management system supporting medication management across care transitions, is designed for pharmacy and care team members to drive medication optimization for at-risk patients in the acute, post-acute and ambulatory care settings. PharmaPoint has been recognized as one of the most innovative, inspiring and fastest growing private companies for six consecutive years (2013-2018) by Inc. Magazine. Headquartered in Birmingham, Ala., we are currently managing pharmacies across the United States. For more information about our company, please visit http://www.pharmapoint.com.

About TransUnion (NYSE: TRU)

TransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing a comprehensive picture of each person so they can be reliably and safely represented in the marketplace. As a result, businesses and consumers can transact with confidence and achieve great things. We call this Information for Good®. TransUnion Healthcare, a wholly owned subsidiary of TransUnion, makes mutual trust possible between patients, providers, and payers by helping them navigate payment uncertainty. Our Revenue Protection® solutions leverage comprehensive data, accurate insights and industry expertise to engage patients early, ensure earned revenue gets paid and optimize payment strategies. TransUnion Healthcare helps over 1,850 hospitals and 550,000 physicians collectively recover more than $1.2 billion annually in revenue. A leading presence in more than 30 countries across five continents, TransUnion provides solutions that help create economic opportunity, great experiences and personal empowerment for hundreds of millions of people. http://www.transunionhealthcare.com

Share article on social media or email:

Gertex Solutions Expands Presence in Ontario with Acquisition of Freepak Inc.


Gertex Solutions Logo

Gertex Solutions is a leading provider of customized packaging materials, products, and services.

This partnership will allow us to expand the reach of our just-in-time delivery service and offer our customers better, faster and even more reliable service.

Gertex Solutions Inc. (Gertex or the Company), a leading provider of customized packaging materials, products, and services, announced today the acquisition of Freepak Inc. (Freepak) based out of Stoney Creek, Ontario. The addition of Freepak’s team of dedicated employees as well as their expansive warehouse space will allow Gertex to meet the growing demand of its existing clients while also expanding the company’s geographic service coverage within Ontario.

Freepak Inc., owned and operated by husband and wife team Joe and Sharon Perks, has provided quality packaging and shipping supplies to customers in the Stoney Creek and Hamilton areas for more than 25 years. Founded in 1992, Freepak quickly grew a large and devoted client base, leading to an expansion of their facilities in 2006 at which point Joe and Sharon bought out their remaining partners to become the sole owners and operators.

“Freepak’s reputation as a reliable full-service provider of packaging materials, along with their central location in the Stoney Creek area are what attracted us most to them,” said Paul Gertin, co-founder of Gertex Solutions. “This partnership will allow us to expand the reach of our just-in-time delivery service and offer our customers better, faster and even more reliable service. We look forward to a long and prosperous future together.”

Gertex will assume full control of Freepak’s operations beginning March 9, 2020. Representatives from Gertex are already conducting onsite operations at Freepak and will be working closely with their team over a 6-month transition period. Freepak’s warehouse, in combination with Gertex’s existing facility, will bring the company’s total available warehouse space to 85,000 sq. ft.

“Having grown such a large and loyal client base over the last 25 years in business, we wanted to find a buyer who could deliver the same quality of service our customers have come to expect from us – and we found that in Gertex,” said Joe Perks. “Both of our companies are dedicated to delivering high-quality products at competitive prices in the shortest amount of time. We couldn’t be happier with this decision, and we look forward to the success this partnership will generate.”

About Gertex Solutions

Established in 1992 by brothers Brian, Michael, and Paul Gertin, Gertex Solutions is North America’s leading provider of customized packaging materials, products, and services. We partner with industry leaders like Sealed Air, Phoenix, BestPack and others to offer our customers innovative tailor-made solutions to help them reduce labour costs, improve efficiencies, and encourage packaging sustainability. With more than 75,000 sq. ft. of warehouse space and our own fleet of transport vehicles, our clients’ packaging supplies are always in stock and always on time. We are proud to provide excellent customer service, dependability, reliability, and just-in-time delivery to all our clients. For more information, please visit http://www.gertexsolutions.com.

Share article on social media or email:

Bestselling Instaflex® Pain Relief Cream Now Available in Innovative Roll-On and Spray Formulas to Eliminate Mess, Provide On-the-Go Relief


I’m thrilled that we’re able to introduce these convenient new options, to eliminate any mess and make it easier to relieve pain on the go. – Dr. Joseph Pergolizzi

Healthy Directions announced today the launch of two new formulas in their popular Instaflex® Pain Relief Cream line—a convenient roll-on and a fast-acting, extra strength spray.

The new ergonomic roll-on applicator dispenses cream quickly and allows for targeted, on-the-spot relief with no mess or waste. The smooth roller ball glides easily to help massage the cream deep into aching muscles for fast, long-lasting comfort.

The new Extra Strength Spray formula features a 360 degree continuous spray nozzle that makes it easy to apply the cooling spray directly onto hard-to-reach areas, where it dries quickly with no greasy residue.

Instaflex Pain Relief products, formulated with an exclusive, patented oxygenated oil, work fast and last for hours, relieving pain from conditions such as arthritis, back pain, strains, and joint and muscle pain.

In a randomized, double-blind, controlled comparison study Instaflex® Pain Relief Cream was shown to be nearly twice as effective at relieving pain as a comparable menthol-only rub.

“Instaflex Pain Relief Cream is an extremely effective and safe way to control pain. I continually hear from people that it is working better than anything else they’ve tried,” said Dr. Joseph Pergolizzi, who developed the Instaflex Pain Cream formula with Healthy Directions. “And now I’m thrilled that we’re able to introduce these convenient new options, to eliminate any mess and make it easier to relieve pain on the go.”

These new extensions are expected to be strong additions to the growing Instaflex product line, according Healthy Directions President Ben Teicher.

“Instaflex Pain Cream is so effective and selling so quickly that we’ve recently had to significantly increase production just to keep it in stock,” said Teicher. “At the same time, we’re working hard to give customers a range of convenient application options to accommodate all of their needs. We’re excited about the convenience and portability of the roll-on and spray and are already hearing rave reviews from our customers.”

Instaflex® brand supplements and pain creams are the top-selling branded joint health and pain relief products at GNC. New Instaflex® Pain Relief Roll-On and Extra Strength Spray are now available at select GNC stores as well as through the Healthy Directions catalog and at HealthyDirections.com.

About Healthy Directions: Healthy Directions LLC, a subsidiary of Adaptive Health LLC, is a leading health publisher and direct-to-consumer retailer of doctor-formulated nutritional supplements and skincare products, dedicated to providing people with a better path to better health. Healthy Directions provides expert guidance and advanced nutritional supplements from some of America’s most knowledgeable and highly respected integrative- and alternative-health doctors including Julian Whitaker, MD; Dr. David Williams; Stephen Sinatra, MD; Aaron Tabor, MD; Drew Sinatra, ND; Richard Wurtman, MD; and Joseph Pergolizzi, Jr., MD. For more information, please visit http://www.HealthyDirections.com/About-Us

About Adaptive Health: Adaptive Health is a leader in science-based product development with a full portfolio of scientifically formulated nutritional health brands, including Nugenix®, Instaflex®, Peptiva®, Lumiday®, Dr. Sinatra®, Dr. Williams™, Dr. Whitaker®, Sleep Answer®, and Trilane®. Adaptive Health products are sold in many major retailers across North America and internationally, as well as via its innovative direct-to-consumer ecommerce platform. For more information, please visit http://www.AdaptiveHealth.com.

Share article on social media or email:

Breaking news as Transpara™ 3D is cleared by FDA for clinical use in the USA


News Image

This is a major breakthrough from ScreenPoint Medical and it means that our new and existing US customers now have access to the power of Transpara 3D for the first time

U.S. FDA clears Transpara 1.6.0 manufactured by ScreenPoint Medical, the first breast AI solution for both 2D and 3D mammography in the USA.

In order to obtain FDA clearance, the company performed a clinical reader study which demonstrated that accuracy of radiologists significantly improved when reading 3D mammograms with support from Transpara. In addition, 3D reading time was significantly reduced to about 35 seconds per exam, bringing it close to 2D reading efficiency.

“We are delighted that the U.S. FDA has cleared Transpara 1.6.0 to be marketed in the USA. This is a major breakthrough from ScreenPoint Medical and it means that our new and existing US customers now have access to the power of Transpara 3D for the first time,” says CEO Nico Karssemeijer. “Multiple independent peer reviewed publications have already demonstrated that Transpara significantly improves accuracy in 2D mammography, now the same applies for 3D.”

“We also understand that reading 3D mammography presents radiologists with huge workload challenges. With feedback from the field, we redesigned the Transpara 1.6.0 interface and utilised our patented co-registration slice technology to optimise reading workflow with advanced navigation support to significantly reduce reading times.”

Pieter Kroese, COO at ScreenPoint Medical adds, “Transpara 1.6.0 heralds a new era in breast AI in terms of 2D and 3D workflow. Transpara is the leading evidence-based breast AI solution for mammography, with clinical installations in over 15 countries and over 500,000 mammograms processed so far by our clinical users. This is a significant achievement and demonstrates the strong trust that we share with our clinical partners and that Transpara breast AI is making a difference for women and the detection, diagnosis and treatment of breast cancer.”

Transpara 1.6.0 is marketed in North America by ScreenPoint Medical Inc, Siemens Healthineers USA and Volpara Solutions.

About ScreenPoint Medical BV.

ScreenPoint Medical is the leading developer of AI driven image analysis technology which enables the automated reading of mammograms and digital breast tomosynthesis examinations. With proven accuracy at least matching that of experienced radiologists, ScreenPoint’s Transpara™ system is the most advanced available, exploiting Big Data, Deep Learning and the latest advances in Artificial Intelligence. The system can identify high risk breast lesions quickly, enabling earlier detection, earlier treatment and a greater chance of survival.

ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, two internationally respected experts in breast imaging, machine learning and computer aided detection.

The company’s Head Office is in Nijmegen, The Netherlands.

For more information, please email info@screenpointmed.com

Share article on social media or email:

PACENation Announces Featured Speakers for the 2020 PACENation Summit in Columbus, OH


PACENation announced today the featured speakers for the 2020 PACENation Summit, the national event dedicated to Property Assessed Clean Energy (PACE). PACE is a voluntary financing option that enables property owners to make critical energy, water and resilience upgrades to their homes and businesses.

The Summit will be held in Columbus, OH from March 30-April 1, and will feature over 25 sessions and collaborative workshops with over 90 expert speakers, including capital providers, state and federal policy makers, commercial property owners and representatives from the largest PACE markets across the country. Attendees will have the opportunity to participate in multiple networking receptions, including a She-PACE reception for women working in PACE, an offsite reception sponsored by Bricker & Eckler, a live PACE project tour, and more. To see the full agenda and learn more about the Summit, visit https://pacenation.org/events.

Featured Speakers:

Yaphett El-Amin is the Executive Director of MOKAN Construction Contractors Assistance Center and President of Efficacy Consulting and Development. A former Missouri state legislator, Yaphett has more than 20 years’ experience in the construction industry, specializing in minority business support and workforce development. Over the past 8 years, Yaphett has also built more than 200 affordable housing units for seniors and working families directly in urban communities.                     

W. Craig Fugate served as President Barack Obama’s FEMA Administrator from May 2009 to January 2017. Previously, he served as Florida Governor Jeb Bush’s Emergency Management Director from 2001-2009. Fugate led FEMA through multiple record-breaking disaster years and oversaw the Federal Government’s response to major events such as the Joplin and Moore Tornadoes, Hurricane Sandy, Hurricane Matthew, and the 2016 Louisiana flooding.                    

Lonnie Hendry, Jr. is Vice President of Commercial Real Estate (CRE) product management with Trepp, LLC with a specialization in valuation, appraisals and financial analysis. With a background spanning 16 years in the commercial real estate industry, he is charged with creating and enhancing Trepp’s CRE products and client solutions.  His experience includes conventional multifamily property management and development, commercial and residential leasing, brokerage and appraisal.                     

Glenn Prickett is Founder and Principal of Rock Creek Strategies, LLC. Glenn launched Rock Creek Strategies in 2019, after three decades of leadership in global development, corporate sustainability, and environmental, natural resource, and climate change policy and practice.                    

For more information and to register for the event, visit http://pacenation.org/events.

PACENation is the national nonprofit association that works to expand access to PACE financing. Our members enable millions of American property owners to increase the efficiency and resiliency of their homes and businesses with PACE. To learn more and join PACENation, visit http://pacenation.org.

Share article on social media or email:

Corban University Announces Nursing Partnership with George Fox University


Corban partners with George Fox to offer nursing

Corban partners with George Fox to offer nursing

“This opportunity will combine two key elements our students are seeking: a quality, biblically-based education with a strong Christian community, and a streamlined path toward a highly-demanded career.” – Dr. Tom Cornman, Provost, Corban University

Corban University recently announced a new opportunity for students to earn their bachelor’s in nursing, in partnership with George Fox University.

Students will be able to complete their first two years of coursework at Corban University, earning an Associate of Science degree. They will then complete two years of upper-division nursing courses through George Fox University School of Nursing, along with practicums at area health facilities, and graduate with a four-year bachelor of science in nursing (BSN) degree.

Up to 15 seats in George Fox’s nursing program (which is accredited by the Commission on Collegiate Nursing Education and is approved by the Oregon State Board of Nursing) will be reserved each year specifically for Corban students, beginning in Fall 2022, streamlining the process for students to earn their nursing degree.

Students will benefit from rigorous coursework in the medical sciences at Corban, in addition to a core Bible curriculum, and will have the opportunity to remain closely connected with the Corban community during all four years of their education, with options to live on campus and continue taking Corban electives. Meanwhile, they’ll take upper-division courses with expert George Fox nursing faculty and complete practicums at health facilities including Salem Health Hospitals & Clinics (Salem, Ore.) and Santiam Hospital (Stayton, Ore.).

Dr. Thomas Cornman, Provost of Corban University, says, “This opportunity will combine two key elements our students are seeking: a quality, biblically-based education with a strong Christian community, and a streamlined path toward a highly-demanded career. We’re excited to partner with such a prestigious institution as George Fox to equip students who will make a difference in the world for Jesus Christ in the field of nursing.”

Dr. Christina Cooper, Department Chair for Math, Science, & Kinesiology at Corban, says, “Corban already benefits from a strong biology department with exceptional faculty and hands-on research and internship opportunities. This new partnership will utilize our current offerings while providing an additional track for our students to pursue in the health field. I’m thrilled that Corban can be a part of providing graduates to fill these high-demand positions.”

Corban’s decision to provide a nursing track option arose from increasing demand, both from prospective students and from employers in today’s marketplace. According to the Bureau of Labor Statistics, jobs for registered nurses are projected to increase by 12% between 2018 and 2028 (the average national for job growth is just 5%).

While the Corban/George Fox nursing track will not be available to transfer students due to the 2-year cohort model, incoming freshmen for Fall 2020 are encouraged to apply to Corban University now. https://www.corban.edu/

About Corban: Corban is a private Christian university with an 85-year history of educating students who will make a difference in the world for Jesus Christ. Situated on a beautiful forested hillside overlooking Oregon’s capital, Corban is only an hour from Portland, the Cascade Mountains, and the Oregon coast. Academic excellence at the undergraduate, graduate, and doctoral levels, as well as online, prepares students for careers as business leaders, educators, medical professionals, politicians, ministry leaders, and more. Expert faculty, a tight-knit community, and opportunities for local and global engagement provide for students’ growth both in and beyond the classroom.

About George Fox University: George Fox is Oregon’s nationally recognized Christian university, providing students with personal attention, global opportunities to learn and serve, and a supportive community that encourages academic rigor and spiritual growth. At George Fox, each student is known—personally, academically, and spiritually.

Learn more about George Fox’s nursing program: https://www.georgefox.edu/nursing/index.html

###

Share article on social media or email:

Azalea Health Offers Free Telehealth App to its Physicians Amid Coronavirus Concerns


Azalea Health (Azalea), a leading provider of cloud-based healthcare IT solutions and services, announced today it would offer its telehealth app for free to providers using Azalea EHR. According to a recent Kaiser Family Foundation poll, nearly six in ten fear widespread coronavirus outbreak and four in ten fear themselves or family being infected. By leveraging telehealth, providers can mitigate patient concerns about traveling and public spaces by providing valuable preventative care virtually.

A large number of Azalea clinicians deliver care in disparate communities. These populations tend to have higher rates of chronic conditions, comorbidities, and mortality. Azalea’s telehealth app allows providers to deliver preventative medicine to the vulnerable and at-risk patients in their communities. Additionally, many clinics run on a tight financial budget. Increased cancellations due to perceived Coronavirus risk could negatively impact revenue and their ability to provide care in the nation’s most needy populations. Telehealth is an effective approach to mitigating revenue risks while ensuring the continuity of care.

“We have witnessed the effectiveness of telehealth with clinicians. Knowing its power, our leadership team expressed urgency in getting this tool in the hands of all of our physicians. It will be useful in keeping patients healthy and out of emergency departments and hospitals. We want to support our clients and ensure that they have the tools they need to support their patients and communities during this critical time,” commented Baha Zeidan, Azalea CEO. “We hope that this uncertain period can lead to an opportunity that opens doors to serious consideration of the value telehealth can bring to practices and patients. And our team is on hand to support these clinicians, as telehealth will be new to many.”

Integrated with Azalea EHR, Azalea Telehealth provides an easy to use app to connect remotely with patients or to allow providers to connect to specialists for consults. Being native to the Azalea platform makes the telehealth app simple to deploy and intuitive to use as users are already familiar with the software.

About Azalea Health

Azalea Health (Azalea) is changing the way health IT platforms connect community-based healthcare providers and patients across the lifecycle of care. Offering a 100% cloud-based integrated solution, Azalea delivers electronic health records, revenue cycle management, and telehealth services designed for rural and community practices and hospitals. Quick to deploy and intuitive to use, Azalea solutions ensure better care coordination and communication – enabling better outcomes and a meaningful competitive advantage. The Azalea platform also provides tools and resources to help customers meet their Meaningful Use requirements, as well as strategies to navigate accountable care and alternative payment models. For more information, visit http://www.azaleahealth.com.

Share article on social media or email: